BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33670609)

  • 21. Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms.
    Liu JQ; Liao XW; Wang XK; Yang CK; Zhou X; Liu ZQ; Han QF; Fu TH; Zhu GZ; Han CY; Su H; Huang JL; Ruan GT; Yan L; Ye XP; Peng T
    BMC Gastroenterol; 2020 Dec; 20(1):415. PubMed ID: 33302876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer.
    Wang OH; Azizian N; Guo M; Capello M; Deng D; Zang F; Fry J; Katz MH; Fleming JB; Lee JE; Wolff RA; Hanash S; Wang H; Maitra A
    PLoS One; 2016; 11(3):e0152300. PubMed ID: 27023625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic Interactions between GW8510 and Gemcitabine in an In Vitro Model of Pancreatic Cancer.
    RĂ¼stem DG; Atay S; Aydin HH; Ak H
    Anticancer Agents Med Chem; 2021 Oct; 21(16):2204-2215. PubMed ID: 33397269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma.
    Wang D; Cui SP; Chen Q; Ren ZY; Lyu SC; Zhao X; Lang R
    BMC Cancer; 2023 Jun; 23(1):601. PubMed ID: 37386391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing the clinical value of baseline [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Li X; Huo L
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4036-4050. PubMed ID: 37493664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients.
    Park W; Bang JH; Nam AR; Jin MH; Seo H; Kim JM; Oh KS; Kim TY; Oh DY
    Cancer Res Treat; 2021 Jan; 53(1):199-206. PubMed ID: 33070562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma.
    Rezagholizadeh F; Tajik F; Talebi M; Taha SR; Shariat Zadeh M; Farhangnia P; Hosseini HS; Nazari A; Mollazadeh Ghomi S; Kamrani Mousavi SM; Haeri Moghaddam N; Khorramdelazad H; Joghataei MT; Safari E
    Front Immunol; 2024; 15():1283364. PubMed ID: 38357542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of p16 protein in pancreatic ductal adenocarcinoma.
    Iwatate Y; Hoshino I; Ishige F; Itami M; Chiba S; Arimitsu H; Yanagibashi H; Nagase H; Yokota H; Takayama W
    Mol Clin Oncol; 2020 Jul; 13(1):83-91. PubMed ID: 32499915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma.
    Zhang Y; Liu Q; Cui M; Wang M; Hua S; Gao J; Liao Q
    Front Immunol; 2021; 12():774435. PubMed ID: 35046938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy.
    Ha H; Nam AR; Bang JH; Park JE; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ; Oh DY
    Oncotarget; 2016 Nov; 7(47):76604-76612. PubMed ID: 27780932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CUL4A Ubiquitin Ligase Is an Independent Predictor of Overall Survival in Pancreatic Adenocarcinoma.
    Tavlas P; Nikou S; Geramoutsou C; Bosgana P; Tsaniras SC; Melachrinou M; Maroulis I; Bravou V
    Cancer Genomics Proteomics; 2024; 21(2):166-177. PubMed ID: 38423594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: implications for adjuvant treatment.
    Fisher SB; Patel SH; Bagci P; Kooby DA; El-Rayes BF; Staley CA; Adsay NV; Maithel SK
    Cancer; 2013 Jan; 119(2):445-53. PubMed ID: 22569992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential processing of let-7a precursors influences RRM2 expression and chemosensitivity in pancreatic cancer: role of LIN-28 and SET oncoprotein.
    Bhutia YD; Hung SW; Krentz M; Patel D; Lovin D; Manoharan R; Thomson JM; Govindarajan R
    PLoS One; 2013; 8(1):e53436. PubMed ID: 23335963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study.
    Guo JC; Zhang P; Zhou L; You L; Liu QF; Zhang ZG; Sun B; Liang ZY; Lu J; Yuan D; Tan AD; Sun J; Liao Q; Dai MH; Xiao GG; Li S; Zhang TP
    EBioMedicine; 2020 May; 55():102767. PubMed ID: 32361251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis.
    Mohamed Abd-El-Halim Y; El Kaoutari A; Silvy F; Rubis M; Bigonnet M; Roques J; Cros J; Nicolle R; Iovanna J; Dusetti N; Mas E
    EBioMedicine; 2021 Sep; 71():103541. PubMed ID: 34425307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients.
    Zhang D; Wang M; Peng L; Yang X; Li K; Yin H; Xia C; Cui F; Huang H; Jin Z
    J Oncol; 2021; 2021():4986227. PubMed ID: 34987579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclin D1, p16(INK) (4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantitative image analysis.
    Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
    APMIS; 2014 Dec; 122(12):1230-9. PubMed ID: 25053516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy.
    Liao X; Han C; Wang X; Huang K; Yu T; Yang C; Huang R; Liu Z; Han Q; Peng T
    Cancer Manag Res; 2018; 10():3255-3271. PubMed ID: 30233242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.